Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cancer: A Propensity Score Matching Analysis-Reference-Cited by-同舟云学术

Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cancer: A Propensity Score Matching Analysis

Published:2023-03 Issue:1 Volume:22 Page:111-119
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Ouyang Huaqiang,Ma Weidong,Si Tongguo,Liu Donglin,Chen Ping,Gerdtsson Anna Sandström,Song Jiahong,Ni Yue,Luo Juanjuan,Yan Zhuchen

Funder

National Key Clinical Specialty Discipline Construction Program of China

National Natural Science Foundation of China

China Scholarship Council

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference25 articles.

1. Factors influencing survival of patients with pancreatic adenocarcinoma and synchronous liver metastases receiving palliative care;Ouyang;Pancreatology,2017

2. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011

3. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine;Von Hoff;N Engl J Med,2013

4. Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial;Wang-Gillam;Lancet,2016

5. Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer;Golan;N Engl J Med,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of image-guided locoregional transarterial chemotherapy in patients with inoperable colorectal cancer: a review;Frontiers in Oncology;2024-08-23